The Latest Breaking News from BLA

Bangkok Life Assurance (BLA) is on track to achieve total premiums of 35.8 billion baht this year, on par with the tally in 2021, but the outlook for next year remains uncertain given the projection of slow growth for the global economy.

It was the kind of attack Pakistani authorities had dreaded.

Pakistani police say a gunman posing as a dental patient shot and killed a dual national Chinese-Pakistani man working at a dental clinic in the southern port city of Karachi before fleeing the scene

A senior Pakistani army officer and his friend were found shot dead on Thursday, two days after militants kidnapped them in the restive southwest province of Balochistan, security officials said.

Recap: Asian shares were mixed while European shares rebounded yesterday as investors digested policy tightening by major central banks.

Shari Baloch, 30, became the first female suicide bomber of the Baloch Liberation Army when she blew herself up.

Shari Baloch blowing herself up to kill three Chinese nationals making analysts wonder if rebels are changing tactics.

A woman suicide bomber who killed three Chinese teachers in Pakistan was a teacher who had enrolled for a master's degree months before her attack, carried out on behalf of separatist insurgents, a Pakistani official said on Wednesday.

The Baloch Liberation Army (BLA), which claimed a deadly attack on Chinese citizens in Karachi on Tuesday, is the most prominent of a number of separatist groups operating against the Pakistani state in the southwestern province of Balochistan.

HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ:SPPI), with a price target of $10. The analyst projects revenues of $170 million for Rolontis and $328 million for poziotinib in 2026. Eflapegrastim (formerly known as Rolontis; to be renamed) is a long-acting granulocyte colony-stimulating factor intended to stimulate neutrophil production for chemotherapy-induced neutropenia…

Bangkok Life Assurance (BLA) expects demand for health insurance to rise in 2022 following the economic recovery and interest rate hikes.